We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR Equipment Designed for Clinical Laboratories

By LabMedica International staff writers
Posted on 10 Dec 2012
A real-time polymerase chain reaction (PCR) instrument has been designed to meet the specific needs of clinical diagnostic laboratories. More...


The apparatus can perform numerous diagnostic functions, including pathogen detection, gene expression analysis, single nucleotide polymorphism (SNP) genotyping, copy number analysis, mutation detection, micro-ribonucleic acid (RNA) and other noncoding RNA analysis, and high-resolution melt analysis.

The QuantStudioDx Real-Time PCR Instrument (Applied Biosystems, Carlsbad, CA, USA) is a Conformité Européenne in vitro diagnostic device (CE-IVD) marked for use in Europe and represents a significant extension of their parent company Life Technologies’ product offerings in the diagnostics arena. The instrument’s touch screen, reagent and sample tracking, and Laboratory Information Management Systems (LIMS) interface are specifically designed for ease of use.

Flexibility is enabled through easily interchangeable thermal cycling blocks that accommodate 96- or 384-well plates and a proprietary quantitative real time PCR (qPCR) microfluidics card, which can perform 48 tests on eight samples concurrently without the need for liquid-handling robots. The card can also be used to design and implement custom tests. Life Technologies (Carlsbad, CA, USA) is currently developing diagnostic tests utilizing this format.

The instrument is being released with CE-marked Quidel Molecular Assay for Clostridium difficile for detection of hospital-acquired infections, which Life Technologies distributes. Additional Quidel Molecular infectious disease applications are currently under development and will be available in 2013, including an influenza A + B Assay, a human metapneuomvirus (hMPV) + respiratory syncytial virus (RSV) Assay, and a herpes simplex virus 1 and 2, and varicella zoster virus (chicken pox and shingles) assay.

Ronnie Andrews, BS, president of Medical Sciences at Life Technologies, said, “Molecular diagnostic tests based on real-time PCR have become indispensable to the clinical laboratory. Molecular testing is the fastest-growing segment of the diagnostics market, and the QuantStudio Dx instrument has unique features that will allow us to capture that market growth.”

Related Links:

Applied Biosystems
Life Technologies



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sample Transportation System
Tempus1800 Necto
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.